Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 649 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$22.43M
Operating Margin
-14.44%
TTM Avg
-13.11%
3Y Avg
-11.14%
5Y Avg
-41.32%
Market Cap
$21.68M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.96M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.29M
Operating Margin
-712.66%
TTM Avg
-610.23%
3Y Avg
-530.97%
5Y Avg
-392.56%
Market Cap
$24.78M
Operating Margin
0.00%
TTM Avg
-461.67%
3Y Avg
-1730.28%
5Y Avg
-1995.34%
Market Cap
$19.23M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.92M
Operating Margin
-835.53%
TTM Avg
-421.37%
3Y Avg
-210.69%
5Y Avg
-1650.61%
Market Cap
$25.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | -14.44% | -13.11% | -11.14% | -41.32% |
| Modular Medical, Inc. (MODD)vs › | $21.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.29M | -712.66% | -610.23% | -530.97% | -392.56% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.78M | 0.00% | -461.67% | -1730.28% | -1995.34% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.92M | -835.53% | -421.37% | -210.69% | -1650.61% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $25.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| NextCure, Inc. (NXTC)vs › | $18.82M | 0.00% | 0.00% | 0.00% | -30.70% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
